Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis.

Wheeler LJ, Desanto K, Teal SB, Sheeder J, Guntupalli SR.

Obstet Gynecol. 2019 Oct;134(4):791-800. doi: 10.1097/AOG.0000000000003463.

PMID:
31503144
2.

Predictors of Discontinuation of Long-Acting Reversible Contraception Before 30 Months of Use by Adolescents and Young Women.

Cohen R, Sheeder J, Teal SB.

J Adolesc Health. 2019 Aug;65(2):295-302. doi: 10.1016/j.jadohealth.2019.02.020. Epub 2019 Jun 10.

PMID:
31196778
3.

Insulin stimulates GLUT4 trafficking to the syncytiotrophoblast basal plasma membrane in the human placenta.

James-Allan LB, Arbet J, Teal SB, Powell TL, Jansson T.

J Clin Endocrinol Metab. 2019 May 21. pii: jc.2018-02778. doi: 10.1210/jc.2018-02778. [Epub ahead of print]

PMID:
31112275
4.

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.

Teal SB, Turok DK, Chen BA, Kimble T, Olariu AI, Creinin MD.

Obstet Gynecol. 2019 Jan;133(1):63-70. doi: 10.1097/AOG.0000000000003034.

5.

Balancing the Risks and Desires for Pregnancy in Older Mothers: Increasing Morbidity, Declining Fertility.

Teal SB, Sheeder J.

JAMA Intern Med. 2018 Dec 1;178(12):1671-1672. doi: 10.1001/jamainternmed.2018.4734. No abstract available.

PMID:
30383079
6.

Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy.

Lazorwitz A, Coleman-Minahan K, Teal SB, Guiahi M.

J Adolesc Health. 2018 Sep;63(3):363-364. doi: 10.1016/j.jadohealth.2018.03.021. Epub 2018 Jul 31.

PMID:
30076014
7.

Factors associated with initiating long-acting reversible contraception immediately after first-trimester abortion.

Fang NZ, Sheeder J, Teal SB.

Contraception. 2018 Oct;98(4):292-295. doi: 10.1016/j.contraception.2018.06.001. Epub 2018 Jun 11.

PMID:
29902476
8.

Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system.

Schreiber CA, Teal SB, Blumenthal PD, Keder LM, Olariu AI, Creinin MD.

Eur J Contracept Reprod Health Care. 2018 Apr;23(2):116-120. doi: 10.1080/13625187.2018.1449825. Epub 2018 Mar 21.

9.

Low Acceptability of Certain Contraceptive Methods among Young Women.

Hoopes AJ, Teal SB, Akers AY, Sheeder J.

J Pediatr Adolesc Gynecol. 2018 Jun;31(3):274-280. doi: 10.1016/j.jpag.2017.11.008. Epub 2017 Dec 1.

PMID:
29198974
10.

What Are Women Told When Requesting Family Planning Services at Clinics Associated with Catholic Hospitals? A Mystery Caller Study.

Guiahi M, Teal SB, Swartz M, Huynh S, Schiller G, Sheeder J.

Perspect Sex Reprod Health. 2017 Dec;49(4):207-212. doi: 10.1363/psrh.12040. Epub 2017 Oct 12.

PMID:
29024351
11.

Postplacental intrauterine device expulsion by 12 weeks: a prospective cohort study.

Goldthwaite LM, Sheeder J, Hyer J, Tocce K, Teal SB.

Am J Obstet Gynecol. 2017 Dec;217(6):674.e1-674.e8. doi: 10.1016/j.ajog.2017.08.001. Epub 2017 Aug 19.

PMID:
28826801
12.

Factors Associated With Contraceptive Method Choice and Initiation in Adolescents and Young Women.

Cohen R, Sheeder J, Kane M, Teal SB.

J Adolesc Health. 2017 Oct;61(4):454-460. doi: 10.1016/j.jadohealth.2017.04.008. Epub 2017 Jul 14.

PMID:
28712596
13.

Motivating factors for dual-method contraceptive use among adolescents and young women: a qualitative investigation.

Lemoine J, Teal SB, Peters M, Guiahi M.

Contraception. 2017 Nov;96(5):352-356. doi: 10.1016/j.contraception.2017.06.011. Epub 2017 Jun 29.

PMID:
28669507
14.

Risk of luteal phase pregnancy with any-cycle-day initiation of subdermal contraceptive implants.

Richards M, Teal SB, Sheeder J.

Contraception. 2017 Apr;95(4):364-370. doi: 10.1016/j.contraception.2017.01.010. Epub 2017 Feb 2.

PMID:
28163088
15.

Validity of self-reported history of Chlamydia trachomatis infection.

Frisse AC, Marrazzo JM, Tutlam NT, Schreiber CA, Teal SB, Turok DK, Peipert JF.

Am J Obstet Gynecol. 2017 Apr;216(4):393.e1-393.e7. doi: 10.1016/j.ajog.2016.12.005. Epub 2016 Dec 14.

16.

A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.

Turok DK, Eisenberg DL, Teal SB, Keder LM, Creinin MD.

Am J Obstet Gynecol. 2016 Nov;215(5):599.e1-599.e6. doi: 10.1016/j.ajog.2016.05.017. Epub 2016 May 12.

PMID:
27180886
17.

Risk of hemorrhage during surgical evacuation for second-trimester intrauterine fetal demise.

Fontenot Ferriss AN, Weisenthal L, Sheeder J, Teal SB, Tocce K.

Contraception. 2016 Nov;94(5):496-498. doi: 10.1016/j.contraception.2016.06.008. Epub 2016 Jun 22.

PMID:
27343749
18.

Comfort With Skills and Knowledge After Immediate Postpartum Intrauterine Device Training.

Goldthwaite LM, Sheeder J, Teal SB, Tocce KM.

Obstet Gynecol. 2016 Oct;128 Suppl 1:6S-11S.

PMID:
27662005
19.

Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.

Cohen R, Sheeder J, Arango N, Teal SB, Tocce K.

Contraception. 2016 Feb;93(2):178-83. doi: 10.1016/j.contraception.2015.10.001. Epub 2015 Oct 22.

PMID:
26475368
20.

Insertion characteristics of intrauterine devices in adolescents and young women: success, ancillary measures, and complications.

Teal SB, Romer SE, Goldthwaite LM, Peters MG, Kaplan DW, Sheeder J.

Am J Obstet Gynecol. 2015 Oct;213(4):515.e1-5. doi: 10.1016/j.ajog.2015.06.049. Epub 2015 Jun 25.

PMID:
26116873
21.

Contraception after delivery and short interpregnancy intervals among women in the United States.

White K, Teal SB, Potter JE.

Obstet Gynecol. 2015 Jun;125(6):1471-7. doi: 10.1097/AOG.0000000000000841.

22.

Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.

Eisenberg DL, Schreiber CA, Turok DK, Teal SB, Westhoff CL, Creinin MD; ACCESS IUS Investigators.

Contraception. 2015 Jul;92(1):10-6. doi: 10.1016/j.contraception.2015.04.006. Epub 2015 Apr 28.

23.

Controversies in family planning: pregnancy termination in women with uterine anatomic abnormalities.

Goldthwaite LM, Teal SB.

Contraception. 2014 Oct;90(4):460-3. doi: 10.1016/j.contraception.2014.05.007. Epub 2014 May 17. Review. No abstract available.

PMID:
24958107
24.

Postpartum contraception: optimizing interpregnancy intervals.

Teal SB.

Contraception. 2014 Jun;89(6):487-8. doi: 10.1016/j.contraception.2014.04.013. Epub 2014 Apr 29. No abstract available.

PMID:
24815100
25.

Contraceptive counseling by general internal medicine faculty and residents.

Dirksen RR, Shulman B, Teal SB, Huebschmann AG.

J Womens Health (Larchmt). 2014 Aug;23(8):707-13. doi: 10.1089/jwh.2013.4567. Epub 2014 Apr 25.

26.

Umbilical cord transection to induce fetal demise prior to second-trimester D&E abortion: in reply.

Tocce K, Leach KK, Teal SB.

Contraception. 2014 May;89(5):473-4. doi: 10.1016/j.contraception.2014.02.009. Epub 2014 Feb 26. No abstract available.

PMID:
24656554
27.

Preventing repeat pregnancy in adolescents: is immediate postpartum insertion of the contraceptive implant cost effective?

Han L, Teal SB, Sheeder J, Tocce K.

Am J Obstet Gynecol. 2014 Jul;211(1):24.e1-7. doi: 10.1016/j.ajog.2014.03.015. Epub 2014 Mar 11.

PMID:
24631431
28.

Umbilical cord transection to induce fetal demise prior to second-trimester D&E abortion.

Tocce K, Leach KK, Sheeder JL, Nielson K, Teal SB.

Contraception. 2013 Dec;88(6):712-6. doi: 10.1016/j.contraception.2013.08.001. Epub 2013 Aug 8.

PMID:
24034582
29.

Feasibility, effectiveness and safety of transvaginal digoxin administration prior to dilation and evacuation.

Tocce K, Sheeder JL, Edwards LJ, Teal SB.

Contraception. 2013 Dec;88(6):706-11. doi: 10.1016/j.contraception.2013.08.005. Epub 2013 Aug 14.

PMID:
24034581
30.

Awareness of long-acting reversible contraception among teens and young adults.

Teal SB, Romer SE.

J Adolesc Health. 2013 Apr;52(4 Suppl):S35-9. doi: 10.1016/j.jadohealth.2013.01.013. Review.

PMID:
23535055
31.

Practicing pelvic examinations by medical students on women under anesthesia: why not ask first?

Tocce K, Teal SB.

Obstet Gynecol. 2013 Feb;121(2 Pt 1):378. doi: http://10.1097/AOG.0b013e3182805d8b. No abstract available.

PMID:
23344291
32.

Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?

Tocce KM, Sheeder JL, Teal SB.

Am J Obstet Gynecol. 2012 Jun;206(6):481.e1-7. doi: 10.1016/j.ajog.2012.04.015. Epub 2012 Apr 16.

PMID:
22631865
33.

IUD use in adolescent mothers: retention, failure and reasons for discontinuation.

Teal SB, Sheeder J.

Contraception. 2012 Mar;85(3):270-4. doi: 10.1016/j.contraception.2011.07.001.

PMID:
22067773
34.

Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.

Tocce K, Sheeder J, Python J, Teal SB.

J Pediatr Adolesc Gynecol. 2012 Feb;25(1):59-63. doi: 10.1016/j.jpag.2011.09.003. Epub 2011 Nov 3.

PMID:
22051792
35.

Predictors of intimate partner violence in women seeking medication abortion.

Roth L, Sheeder J, Teal SB.

Contraception. 2011 Jul;84(1):76-80. doi: 10.1016/j.contraception.2010.11.005. Epub 2010 Dec 24.

PMID:
21664514
36.

The methodology for developing a prospective meta-analysis in the family planning community.

Turok DK, Espey E, Edelman AB, Lotke PS, Lathrop EH, Teal SB, Jacobson JC, Simonsen SE, Schulz KF.

Trials. 2011 Apr 29;12:104. doi: 10.1186/1745-6215-12-104.

37.

Efficacy, acceptability and safety of medication abortion in low-income, urban Latina women.

Teal SB, Harken T, Sheeder J, Westhoff C.

Contraception. 2009 Nov;80(5):479-83. doi: 10.1016/j.contraception.2009.04.012. Epub 2009 Jun 10.

PMID:
19835724
38.

Adolescent childbearing ambivalence: is it the sum of its parts?

Sheeder J, Teal SB, Crane LA, Stevens-Simon C.

J Pediatr Adolesc Gynecol. 2010 Apr;23(2):86-92. doi: 10.1016/j.jpag.2009.06.002. Epub 2009 Sep 5.

PMID:
19734075
39.

Multivalvular bacterial endocarditis after suction curettage abortion.

Tocce K, Teal SB.

Obstet Gynecol. 2008 Nov;112(5):1179; author reply 1180-1. doi: 10.1097/AOG.0b013e31818cb8bf. No abstract available.

PMID:
18978123
40.

Current management of ectopic pregnancy.

Mukul LV, Teal SB.

Obstet Gynecol Clin North Am. 2007 Sep;34(3):403-19, x. Review.

PMID:
17921007
41.

Pregnancy outcome after transcervical hysteroscopic sterilization.

Hastings-Tolsma M, Nodine P, Teal SB, Embry J.

Obstet Gynecol. 2007 Aug;110(2 Pt 2):504-6.

PMID:
17666644
42.

Contraception for women with chronic medical conditions.

Teal SB, Ginosar DM.

Obstet Gynecol Clin North Am. 2007 Mar;34(1):113-26, ix. Review.

PMID:
17472868
43.

Medical therapies for chronic menorrhagia.

Nelson AL, Teal SB.

Obstet Gynecol Surv. 2007 Apr;62(4):272-81. Review.

PMID:
17371607
44.

Predictors of acceptability of medication abortion.

Teal SB, Dempsey-Fanning A, Westhoff C.

Contraception. 2007 Mar;75(3):224-9. Epub 2007 Jan 16.

PMID:
17303494
45.

Levonorgestrel-only dosing strategies for emergency contraception.

Hansen LB, Saseen JJ, Teal SB.

Pharmacotherapy. 2007 Feb;27(2):278-84. Review.

PMID:
17253917
46.

Essure: hysteroscopic sterilization.

Hastings-Tolsma M, Nodine P, Teal SB.

J Midwifery Womens Health. 2006 Nov-Dec;51(6):510-4. Review.

PMID:
17081943
47.

A cautionary tale: fatal outcome of methotrexate therapy given for management of ectopic pregnancy.

Teal SB.

Obstet Gynecol. 2006 Jun;107(6):1420-1; author reply 1421. No abstract available.

PMID:
16738176
48.

Inadvertent vesicular placement of a vaginal contraceptive ring presenting as persistent cystitis.

Teal SB, Craven WM.

Obstet Gynecol. 2006 Feb;107(2 Pt 2):470-2.

PMID:
16449153
49.

Resident job satisfaction: one year of duty hours.

Lund KJ, Teal SB, Alvero R.

Am J Obstet Gynecol. 2005 Nov;193(5):1823-6.

PMID:
16260242
50.

Resident job satisfaction: will 80 hours make a difference?

Lund KJ, Alvero R, Teal SB.

Am J Obstet Gynecol. 2004 Nov;191(5):1805-10.

PMID:
15547569

Supplemental Content

Support Center